- Home
- ZLAB vs UTG Comparison
ZLAB vs UTG Comparison
Compare ZLAB & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- UTG
- Stock Information
- Founded
- ZLAB 2013
- UTG 2003
- Country
- ZLAB China
- UTG United States
- Employees
- ZLAB N/A
- UTG N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- UTG Investment Managers
- Sector
- ZLAB Health Care
- UTG Finance
- Exchange
- ZLAB Nasdaq
- UTG Nasdaq
- Market Cap
- ZLAB 3.6B
- UTG 3.2B
- IPO Year
- ZLAB 2017
- UTG N/A
- Fundamental
- Price
- ZLAB $33.57
- UTG $36.87
- Analyst Decision
- ZLAB Buy
- UTG
- Analyst Count
- ZLAB 5
- UTG 0
- Target Price
- ZLAB $54.28
- UTG N/A
- AVG Volume (30 Days)
- ZLAB 718.8K
- UTG 317.8K
- Earning Date
- ZLAB 08-07-2025
- UTG 01-01-0001
- Dividend Yield
- ZLAB N/A
- UTG 7.28%
- EPS Growth
- ZLAB N/A
- UTG N/A
- EPS
- ZLAB N/A
- UTG 9.86
- Revenue
- ZLAB $418,326,000.00
- UTG $96,107,593.00
- Revenue This Year
- ZLAB $44.07
- UTG N/A
- Revenue Next Year
- ZLAB $49.13
- UTG N/A
- P/E Ratio
- ZLAB N/A
- UTG $3.20
- Revenue Growth
- ZLAB 43.72
- UTG 8.35
- 52 Week Low
- ZLAB $16.01
- UTG $25.26
- 52 Week High
- ZLAB $44.34
- UTG $35.29
- Technical
- Relative Strength Index (RSI)
- ZLAB 44.39
- UTG 71.28
- Support Level
- ZLAB $32.31
- UTG $36.05
- Resistance Level
- ZLAB $36.53
- UTG $36.50
- Average True Range (ATR)
- ZLAB 1.11
- UTG 0.35
- MACD
- ZLAB -0.20
- UTG 0.02
- Stochastic Oscillator
- ZLAB 27.12
- UTG 100.00
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.